Pharma D-mand Logo

Lyo-Modelling
Reduce risks on the road to commercialization through process understanding

July 10, 2024 – 4pm (CEST) / 10am (EDT)

Reduce risks on the road to commercialization through process understanding

Lyophilization is a key technology in the manufacturing of stable drug products for biopharmaceuticals by gently removing water at low temperature and pressure conditions. The complexity of the lyophilization process poses challenges when it comes to achieving consistent product quality and process efficiency. This webinar presents a comprehensive overview of a lyophilization model including a robustness analysis, highlighting the significance of predictive models and robustness assessment methodologies in optimizing process parameters and ensuring product quality.

The presented lyophilization model simulates the primary drying phase, the longest and most critical phase. We will present the model structure, validation experiments and use cases. The model integrates thermodynamic principles, heat and mass transfer equations, and material properties to predict critical process parameters such as product temperature, ice sublimation rate and probabilities of certain failure such as collapse, choked-flow or meltback. By providing insights into the process dynamics and performance under different operating conditions, these models facilitate process optimization, scale-up, and technology transfer. The tool enables in silico robustness analysis which plays a vital role in assessing the sensitivity of lyophilization processes to variations in process parameters, equipment characteristics, and material attributes. Thus, the acceptable ranges of chamber pressure and shelf temperature can be identified to ensure product quality and consistency.

In conclusion, lyophilization modelling and robustness analysis offer valuable tools for optimizing process parameters, minimizing variability, and ensuring product quality and consistency in freeze-drying operations. Continued research and innovation in this field are essential to address emerging challenges and advance the state-of-the-art in lyophilization technology.

This webinar will address the following challenges:

Speakers

Prof. Dr. Wolfgang Frieß

Ludwig-Maximilians-Universitaet Muenchen Department of Pharmacy – Center for Drug Research Pharmaceutical Technology and Biopharmaceutics

Dr. Brecht Vanbillemont

Senior Scientist, Coriolis Pharma

Learning Objectives:

Prof. Dr. Wolfgang Frieß

Prof. Dr. Wolfgang Frieß is an expert in protein formulation development, stability, and processing, drying technologies including freeze-drying and spray-drying as well as drug delivery. Since 2001 he is a professor for Pharmaceutical Technology and Biopharmaceutics at the LMU Munich. Prof. Dr. Wolfgang Frieß has collected more than 30 years of experience in pharmaceutical technology while working at the University of Erlangen (Germany), Genetics Institute – now Pfizer (Andover, MA, USA), and the University of Illinois (Chicago, IL, USA). Prof. Dr. Wolfgang Frieß is the co-editor of the EJPB (European Journal of Pharmaceutics and Biopharmaceutics) and has published over 150 research papers, patents, and book chapters.

Dr. Brecht Vanbillemont

Dr. Brecht Vanbillemont, a senior scientist at Coriolis Pharma in Munich, Germany, specialized in lyophilization process and formulation development. Dr. Vanbillemont is a licensed pharmacist and qualified person. He has directed numerous CRO development studies across various modalities. Dr. Vanbillemont oversees the different aspects of drug product development, from formulation screening to process optimization and late-phase robustness studies. He holds a doctoral degree from Ghent University, where his research focused on continuous freeze-drying of parenterals and orally disintegrating tablets under the guidance of Prof. Thomas De Beer. He has authored 18 scientific publications and presented at numerous international conferences. Dr. Vanbillemont was a visiting scholar for 6 months at the University of Colorado, mentored by Prof. John Carpenter, further enriching his expertise in the field.